Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Cerence Inc’s stock clocked out at $9.65, up 4.66% from its previous closing price of $9.22. In other words, the price has increased by $4.66 from its previous closing price. On the day, 1.09 million shares were traded. CRNC stock price reached its highest trading level at $10.1258 during the session, while it also had its lowest trading level at $9.35.
Ratios:
To gain a deeper understanding of CRNC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.80. For the most recent quarter (mrq), Quick Ratio is recorded 1.27 and its Current Ratio is at 1.29. In the meantime, Its Debt-to-Equity ratio is 2.24 whereas as Long-Term Debt/Eq ratio is at 1.71.
On January 22, 2025, Needham Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $16.
Wells Fargo Downgraded its Overweight to Equal Weight on May 10, 2024, whereas the target price for the stock was revised from $25 to $6.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 28 ’25 when MR THOMAS L. BEAUDOIN bought 10,000 shares for $9.40 per share.
Mentz Christian sold 3,600 shares of CRNC for $53,028 on Feb 13 ’25. The EVP, Chief Revenue Officer now owns 142,747 shares after completing the transaction at $14.73 per share. On Feb 03 ’25, another insider, BEAUDOIN THOMAS L, who serves as the Director of the company, sold 5,000 shares for $11.68 each. As a result, the insider received 58,400 and left with 173,966 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRNC now has a Market Capitalization of 416870336 and an Enterprise Value of 579247296. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.71 while its Price-to-Book (P/B) ratio in mrq is 3.44. Its current Enterprise Value per Revenue stands at 2.373 whereas that against EBITDA is -51.932.
Stock Price History:
The Beta on a monthly basis for CRNC is 2.90, which has changed by -0.045499504 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, CRNC has reached a high of $27.50, while it has fallen to a 52-week low of $2.34. The 50-Day Moving Average of the stock is 4.76%, while the 200-Day Moving Average is calculated to be 37.84%.
Shares Statistics:
It appears that CRNC traded 1.65M shares on average per day over the past three months and 892930 shares per day over the past ten days. A total of 42.99M shares are outstanding, with a floating share count of 39.95M. Insiders hold about 7.53% of the company’s shares, while institutions hold 78.87% stake in the company. Shares short for CRNC as of 1744675200 were 8865162 with a Short Ratio of 5.37, compared to 1741910400 on 9181437. Therefore, it implies a Short% of Shares Outstanding of 8865162 and a Short% of Float of 20.549999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
